Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants

Self-Monitoring Focus Groups With Vibrant Lives Pasadena Participants

This study investigates how individuals feel about a dietary mobile application. Information collected from focus groups and interviews may help doctors and mobile application developers to determine preferences and participant feedback about the appeal and usefulness of a mobile application.

Study Overview

• Status: Recruiting
• Conditions: Obesity-Related Malignant Neoplasm
• Intervention / Treatment: Other: Survey Administration; Behavioral: Discussion; Other: Interview

Detailed Description

PRIMARY OBJECTIVE:

I. To gather qualitative data to assess appeal, preference, and usefulness of a food and beverage self-monitoring mobile application.

OUTLINE:

PHASE I: Participants attend 4 sessions of focus groups.

PHASE II: Participants attend virtual Zoom interviews or one-on-one interviews.

• Study Type: Observational
• Enrollment (Estimated): 39

Contacts and Locations

• Study Contact: Name: Karen M Basen-Engquist; Phone Number: 713-745-3123; Email: kbasenen@mdanderson.org

Study Locations

• United States
  • Texas
    • Houston, Texas, United States, 77030
      • Recruiting
      • M D Anderson Cancer Center
      • Contact: Karen M. Basen-Engquist; Phone Number: 713-745-3123
      • Principal Investigator: Karen M. Basen-Engquist

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Participants who have completed a weight loss program

Description

Inclusion Criteria:

• Pasadena Independent School District (ISD) employees who have completed the 6-month Vibrant Lives weight loss program or adults who have completed a weight loss program within the last 12 months

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Observational (focus group, interview); PHASE I: Participants attend 4 sessions of focus groups. PHASE II: Participants attend virtual Zoom interviews or one-on-one interviews.	Other: Survey Administration; Ancillary studies; Behavioral: Discussion; Attend focus groups; Other Names: Discuss; Other: Interview; Attend interviews

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Preferences of food and beverage self-monitoring methodology and respective feedback messages	Thematic and narrative analyses will be conducted from the transcriptions to gain an understanding for the preferences of food and beverage self-monitoring methodology and respective feedback messages.	Up to 3 years

Collaborators and Investigators

• Sponsor: M.D. Anderson Cancer Center
• Investigators: Principal Investigator: Karen M Basen-Engquist, M.D. Anderson Cancer Center

Publications and helpful links

Helpful Links

• MD Anderson Cancer Center Website

Study record dates

Study Major Dates

• Study Start (Actual): July 3, 2018
• Primary Completion (Estimated): April 30, 2027
• Study Completion (Estimated): April 30, 2027

Study Registration Dates

• First Submitted: October 26, 2020
• First Submitted That Met QC Criteria: October 26, 2020
• First Posted (Actual): November 2, 2020

Study Record Updates

• Last Update Posted (Actual): February 19, 2026
• Last Update Submitted That Met QC Criteria: February 17, 2026
• Last Verified: February 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Neoplasms; Health Care Quality, Access, and Evaluation; Investigative Techniques; Epidemiologic Methods; Data Collection; Health Care Evaluation Mechanisms; Quality of Health Care; Public Health; Environment and Public Health; Interviews as Topic
• Other Study ID Numbers: PA18-0407 (Other Identifier: M D Anderson Cancer Center); NCI-2020-07542 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No